Earlier Rheumatoid Arthritis Treatment

New Drug for Rheumatoid Arthritis Favored by FDA Panel - Yahoo! News

news.yahoo.com — “From Yahoo! News: For those who have rheumatoid arthritis and are just not getting any benefits from their current treatment regimen, there could be hope on the horizon. A major drug company, Pfizer, has developed a new drug that has received FDA panel favor. This does not mean that the FDA will definitely approve it.” View full resource at news.yahoo.com

Most Recently Shared on May 12, 2012 at 7:44 am By:

New Drug for Rheumatoid Arthritis Favored by FDA Panel: For those who have rheumatoid arthritis and are just not... http://t.co/QmqUK6js

MedWire News - Bone Health - Biologics no better than DMARDs for refractory RA

medwire-news.md — “MedWire News Biologic treatment offers little long-term clinical benefit over conventional treatment for patients with rheumatoid arthritis who fail to respond to initial methotrexate therapy, Swedish researchers report. MedWire News” View full resource at medwire-news.md

Most Recently Shared on May 12, 2012 at 7:07 am By:

Biologics no better than DMARDs for refractory RA: Biologic treatment offers little long-term clinical benefit o... http://t.co/WanydNSR

Advisory Panel Recommends FDA Approval Of Rheumatoid Arthritis Drug - Health News - redOrbit

redorbit.com — “An advisory panel recommends that the FDA consider approving Pfizer’s pill to treat rheumatoid arthritis. The pill, tofacitinib, would be sold to patients who don’t respond to traditional rheumatoid arthritis treatments.” View full resource at redorbit.com

Most Recently Shared on May 11, 2012 at 7:41 pm By:

Advisory Panel Recommends FDA Approval Of Rheumatoid Arthritis Drug: Connie K. Ho for http://t.co/6eqBD5l3 An adv... http://t.co/d6SkusIQ

FDA Panel in Favor of First JAK Inhibitor for RA

painlive.com — “The FDA Arthritis Advisory Committee voted to recommend approval of tofacitinib, a new treatment for moderate to severe rheumatoid arthritis (RA), Pfizer announced.” View full resource at painlive.com

Most Recently Shared on May 11, 2012 at 4:00 pm By:

HCPLive Pain Management

FDA Panel in Favor of First JAK Inhibitor for RA http://t.co/rlqs8u3o

FDA panel urges approval for Pfizer arthritis drug - Yahoo! News

news.yahoo.com — “From Yahoo! News: An advisory committee to the US Food and Drug Administration on Wednesday urged US regulators to approve a new treatment for rheumatoid arthritis made by the pharmaceutical giant Pfizer.” View full resource at news.yahoo.com

Most Recently Shared on May 10, 2012 at 1:34 am By:

FDA panel urges approval for Pfizer arthritis drug: An advisory committee to the US Food and Drug Administration... http://t.co/FlnNPjEd

Successful childbearing in two women with rheumatoid arthritis and a history of miscarriage after etanercept treatment. | ResearchGate

researchgate.net — “Publication » Successful childbearing in two women with rheumatoid arthritis and a history of miscarriage after etanercept treatment..” View full resource at researchgate.net

Most Recently Shared on May 9, 2012 at 2:02 pm By:

Dr. Shashank Akerkar Doctor, Internist, Rheumatologist, and Physician

Is Enbrel safe in pregnancy ? http://t.co/pNufla2q #rheum #lupus

Reuters Health Health News

FDA staff question Pfizer arthritis drug benefits | Reuters

in.reuters.com — “WASHINGTON (Reuters) - U.S. drug reviewers on Monday questioned whether the benefits of Pfizer Inc's experimental treatment for rheumatoid arthritis outweighed its risks of cancerous cells and infections.The” View full resource at in.reuters.com

Most Recently Shared on May 7, 2012 at 2:36 pm By:

FDA staff question Pfizer arthritis drug benefits http://t.co/WXFuqyft

4 weeks ago...

Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial : The Lancet

thelancet.com — “Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial. B...” View full resource at thelancet.com

Most Recently Shared on May 4, 2012 at 6:36 pm By:

[Articles] Conventional combination treatment versus biological treatment in methotrexate-refractory early rheum... http://t.co/eQiIWYgz

4 weeks ago...

News-Medical.Net Health News

Enrollment complete in Zalicus Synavive Phase 2b clinical trial for rheumatoid arthritis

news-medical.net — “Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced it has completed enrollment with 292 patients enrolled in the SYNERGY trial, a Phase 2b clinical trial designed to evaluate the safety and efficacy of Synavive, a low-dose glucocorticoid with the potential for amplified immuno-inflammatory benefits, in patients with rheumatoid arthritis (RA).” View full resource at news-medical.net

Most Recently Shared on April 30, 2012 at 6:18 pm By:

Arthritis News: Enrollment complete in Zalicus Synavive Phase 2b clinical trial for rheumatoid arthritis: Zalicu... http://t.co/RMkrrbrn

1 month ago...

It All Comes Out in the Wash: Comparing Different Treatments & Approaches | RA Education | Rheumatoid Arthritis Warrior

rawarrior.com — “It All Comes Out in the Wash: Comparing Different Treatments & Approaches | RA Education | Rheumatoid Arthritis Warrior” View full resource at rawarrior.com

Most Recently Shared on April 20, 2012 at 9:00 am By:

Kelly Young ePatient

Whether expensive Biologics are any better than cheaper DMARDs. Whether 1 Biol is better than another. Discussing... http://t.co/aqPongJt

1 month ago...

What Can I Do About My Rheumatoid Arthritis? - Patient Power

patientpower.info — “In this podcast, Dr. Calvin Brown Jr., from Northwestern Memorial Hospital, discusses recent advances in treatment for rheumatoid arthritis, shares ongoing research efforts and explores whether a cure is within our reach. Dr. Brown also stresses the …” View full resource at patientpower.info

Most Recently Shared on April 5, 2012 at 5:55 pm By:

Andrew Schorr Support

What Can I Do About My Rheumatoid Arthritis? - Patient Power - http://t.co/LIjr7BS1

New Guidelines Issued for Rheumatoid Arthritis Treatment

painlive.com — “The 2008 American College of Rheumatology guidelines for the treatment of rheumatoid arthritis have been updated for 2012, according to a special article published in the May issue of Arthritis Care & Research.” View full resource at painlive.com

Most Recently Shared on April 5, 2012 at 5:35 pm By:

HCPLive Pain Management

New Guidelines Issued for Rheumatoid Arthritis Treatment http://t.co/ge7gIlIy

MedPage Today Health News

Medical News:New Guidelines Focus on Early RA Treatment - in Rheumatology, Arthritis from MedPage Today

medpagetoday.com — “Medical News:New Guidelines Focus on Early RA Treatment - in Rheumatology, Arthritis from MedPage Today” View full resource at medpagetoday.com

Most Recently Shared on April 2, 2012 at 5:21 pm By:

New Guidelines Focus on Early #RheumatoidArthritis Treatment http://t.co/GnQalJBs

Lisa Emrich Patient Expert

Multiple Sclerosis Tissue Donation: Your Brain on Research - What is MS? - Multiple Sclerosis

healthcentral.com — “As a person living with multiple sclerosis and rheumatoid arthritis, my options for organ and tissue donation are limited. Earlier this week, I posted reg...” View full resource at healthcentral.com

Most Recently Shared on March 31, 2012 at 6:39 pm By:

Multiple Sclerosis Tissue Donation: Your Brain on Research: As a person living with multiple ... http://t.co/A5XUJocA via @healthcentral